Pharma & Biopharma Manufacturing
Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. ...
July 27, 2021 | News
First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualific...
July 26, 2021 | News
Sinopec Jianghan Salt Chemical Hubei Co., Ltd. (the "Company"), a subsidiary of China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec"), has comp...
July 25, 2021 | News
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as &ldq...
July 22, 2021 | News
BioNTech SE and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies have entered into a purchase ag...
July 22, 2021 | News
SP Scientific Products (SP) announces a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT) in Dublin, Irel...
July 20, 2021 | News
Adds integrated biologics development platform from discovery through GMP manufacturing Curia, formerly AMRI, a leading contract research, development and...
July 19, 2021 | News
SP Scientific Products (SP) announces that it has expanded its freeze dryer loader range with the launch of two new fully GMP compliant loading system...
July 16, 2021 | News
The biopharma industry offers big rewards – but it poses big risks, too. Rather than fearing the unknown, the concept of optionality can help you bet...
July 15, 2021 | Opinion | By Firman Ghouze, Cytiva, and Uriel Kusiatin, Provista Diagnostics Inc.
Batavia Biosciences announces today that they have successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa...
July 15, 2021 | News
Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that ad...
July 12, 2021 | News
Agreement to encompass co-development and optimization of protocols for intensified and continuous viral vector production for cell and gene therapies and ...
July 07, 2021 | News
Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...
June 30, 2021 | News
Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate t...
June 30, 2021 | News
Most Read
Bio Jobs
News